In cases of congestive heart failure, where oral medications fail to help the patient survive, cardiac assist devices are used. Heart failure is majorly caused due to weakening of heart muscles, which diminishes the heart’s ability to ensure optimal blood supply throughout the body. In such cases, the heart can be donated to the suffering patient, however, the number of donors for heart transplantation is reducing, due to rapid improvement in healthcare, which increases the life span of several patients. This in turn, is increasing the demand for cardiac assist devices, further creating a lucrative environment for growth of the cardiac assist devices market. Furthermore, rapid advancements in technology coupled with increasing number of cardiac surgeries among heart patients are factors contributing to growth of the cardiac assist devices market.
The market for cardiac assist devices is majorly driven by the growing geriatric population, increasing prevalence of heart failure, high adoption of cardiac assist devices. These devices are also used as a BTT or Bridge-To-Transplantation, BTR or Bridge-To-Recovery, and/or DT or Destination Therapy depending upon the severity of the disease and necessity of the patient. Advancements in technology such as minimally invasive procedures and enhanced efficiency are expected to fuel growth of this market in the near future. However, alternative treatments such as implanting artificial pacemaker pose as threats to growth of the cardiac assist devices market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients